How many courses of Rozebalamin (methylcobalamin) is needed to treat ALS?

Rozebalamin(methylcobalamin) treatment for ALS (ALS) is usually long-term, and there is no fixed "course of treatment" concept. ALS is a progressive neurodegenerative disease, so the goal of treatment is to slow progression and delay loss of function, rather than to completely cure it. In this context, the use of Rozebalamin is usually ongoing, and patients may need long-term use until the doctor makes adjustments based on changes in the patient's condition.

In the early stage of treatment, the doctor will recommend starting to use drugs based on the patient's specific condition and treatment response, and regularly monitor changes in the patient's symptoms. If the drug is effective in slowing the progression of the disease, it is usually continued. During this time, patients receive multiple injections each month for months or even years. The specific length of treatment depends on the patient's response, and some patients may show good results in long-term treatment and be able to continue to maintain a stable state.

For most ALS patients, Rozebalamin treatment is not divided into courses in the traditional sense, but is a long-term management process. During treatment, the patient's condition will change according to individual differences, and the doctor will adjust the treatment strategy according to the progress of the condition. For example, frequency or dosage may be adjusted based on the patient's degree of functional loss and side effects. In some cases, patients may experience a degree of stabilization, at which point doctors may recommend extending treatment intervals or reducing medication use as needed.

In short,Rozebalamin’s treatment cycle is not fixed, but is personalized based on the patient’s actual condition. The goal of treatment is to delay the progression of the disease and alleviate symptoms as much as possible, so patients usually need to continue using the drug under the guidance of a doctor, regularly evaluate the effect and adjust the treatment plan.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html